Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Ludwig, Alison ^a   Lucero Obusan, Cynthia ^a   Schirmer, Patricia ^a   Winston, Carla ^a   Holodniy, Mark ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Human; Influenza; Myocardial ischemia; Veterans health

Indexed keywords

ANTIVIRUS AGENT; BIOLOGICAL MARKER; CREATINE KINASE MB; INFLUENZA VACCINE; OSELTAMIVIR; TROPONIN I;

ACUTE CARDIAC INJURY; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; FEMALE; HEART INJURY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MYOCARDITIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNITED STATES; VETERAN; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; INFLUENZA, HUMAN; MIDDLE AGED; TIME FACTOR; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TIME FACTORS; UNITED STATES; VACCINATION; VETERANS; YOUNG ADULT;

EID: 84942673488     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-015-0095-0     Document Type: Article

References (44)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-40.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-86.
3. Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol. 2013;167:2397-403.
4. Mamas AM, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol. 2008;130:304-9.
5. Caussin C, Escolando S, Mustafic H, Bataille S, Tafflet M, Chatignoux E, et al. Short-term exposure to environmental parameters and onset of ST elevation myocardial infarction. The CARDIO-ARSIF registry. Int J Cardiol. 2015;183:17-23.
6. Guan X, Yang W, Sun X, Wang L, Ma B, Li H, et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res. 2012;61:591-8.
7. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naquib S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003;107:762-8.
8. Fleming M, Elliot A. The impact of influenza on the health and health care utilization of elderly people. Vaccine. 2005;23 Suppl 1:1-9.
9. Greaves K, Oxford JS, Price CP, Clarke GH, Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponin I and T in 152 patients with acute influenza infection. Arch Intern Med. 2003;163:165-8.
10. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systemic review. Lancet. 2009;9:601-10.
11. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiseley OI, Lobzin YV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. Eur Heart J. 2007;28:1205-10.
12. Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep. 1932;47:2159-79.
13. Housworth J, Langmuir AD. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol. 1974;100:40-8.
14. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions and deaths in winter. Commun Dis Public Health. 2000;3:32-8.
15. Barker WH, Mullooly JP. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol. 1982;115:479-80.
16. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidmiol. 2004;160:492-502.
17. Warren-Gash C, Bhaskaran K, Hayward A, Leung GM, Lo SV, Wong CM, et al. Circulating influenza virus, climactic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis. 2011;203:1710-8.
18. Lichenstein R, Magder LS, King RE, King JC. The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a seven-year period. J Infect Dis. 2012;206:821-7.
19. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ. 2010;182:1617-23.
20. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-8.
21. Ciszewski A, Bilinksa ZT, Brydak LB, Kepka C, Kruk M, Romanoswska M, et al. Influenza infection in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29:1350-8.
22. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-32.
23. Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L. Use of oseltamivir after influenza infection is associated with reduced recurrence adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2009;2:108-15.
24. Department of Veterans Affairs, National Center for Veterans Analysis and Statistics: Disability Compensation and Patient Expenditures: FY2000 to FY2013. [http://www.va.gov/vetdata/Utilization.asp] Accessed 9/29/2015.
25. United States Department of Veteran Affairs, National Center for Veteran Analysis and Statistics. Profile of Veterans 2011: data from the American Community Study. [http://www.va.gov/VETDATA/docs/SpecialReports/ Profile_of_Veterans_2011.pdf] Accessed 9/29/2015.
26. Census Bureau US. Decennial census of population, 1940 to. 2010.
27. Richlie DG, Winters S, Prochazka AV. Dyslipidemia in veterans. Multiple risk factors may break the bank. Arch Intern Med. 1991;151:1433-6.
28. Steinman MA, Lee SJ, John Boscardin W, Miao Y, Fung KZ, Schwartz JB. Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc. 2012;60:1872-80.
29. Agha Z, Lofgren RP, VanRuiswyk JV, Layde PM. Are patients at Veterans Affairs Medical Centers sicker? Arch Intern Med. 2000;160:3752-7.
30. Schirmer P, Lucero C, Oda G, Lopez J, Holodniy M. Effective detection of the 2009 H1N1 influenza pandemic in the U.S. Veterans Affairs medical centers using a national electronic biosurveillance system. PLoS ONE. 2010;5:e9533.
31. Department of Health and Human Services, Centers for Disease Control and Prevention. National Center for Health Statistics. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), Sixth Edition 2002. http://www.cdc.gov/nchs/icd/icd9cm.htm Accessed 9/29/2015.
32. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-98.
33. Meier CR. The possible role of infections in acute myocardial infarction. Biomed Pharmacother. 1999;53:397-404.
34. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J. 2008;29:96-103.
35. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol. 1984;53:481-2.
36. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol. 2010;55:2118-24.
37. de Filippi CR, Tocchi M, Parmar RJ, Rosanio S, Abreo G, Potter MA, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol. 2000;35:1827-34.
38. Fagnoul D, Pasquier P, Bodson L, Ortiz JA, Vincent JL, De Backer D. Myocardial dysfunction during H1N1 influenza infection. J Crit Care. 2013;28:321-7.
39. Hennekens CH, Dalen JE. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions. Am J Med. 2013;126:373-8.
40. Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol. 2003;91:9B-13B.
41. Centers for Disease Control and Prevention. MMWR Recommend Rep. 2011;60(No. RR-1):7-11.
42. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recommend Rep. 2013;62(RR No. 7):1-43.
43. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et al. Antivirals for treatment of influenza, a systemic review and meta-analysis of observational studies. Ann Intern Med. 2012;156:512-24.
44. Department of Veterans Affairs. Washington: Veterans Health Administration, Public Health Strategic Healthcare group. VA influenza Manual 2012-2013. [http://www.publichealth.va.gov/InfectionDontPassItOn] Accessed 9/29/2015.